BIOMARIN PHARMACEUTICAL INC OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax
BIOMARIN PHARMACEUTICAL INC (BMRN) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax of -$2.96 million for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-02.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax · last filed 2015-11-02
- BIOMARIN PHARMACEUTICAL INC oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for the quarter ending 2015-09-30 was -$2.96M, a 297.99% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for the quarter ending 2015-06-30 was -$1.98M, a 351.01% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for the quarter ending 2015-03-31 was $4.16M, a 406.70% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for the quarter ending 2014-12-31 was -$175.00K, a 101.79% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for fiscal 2014 was $2.93M, a 17.09% decline from fiscal 2013.
- BIOMARIN PHARMACEUTICAL INC oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for fiscal 2013 was $3.54M.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 3 month as first filed | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 6 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 6 month as first filed | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 9 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 9 month as first filed | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 12 month |
|---|---|---|---|---|---|---|---|
| 2015-09-30 | -$2.96M 10-Q · filed 2015-11-02 | -$4.94M derived: sum of 2 quarters · filed 2015-11-02 | -$779.00K 10-Q · filed 2015-11-02 | -$954.00K derived: sum of 4 quarters · filed 2015-11-02 | |||
| 2015-06-30 | -$1.98M 10-Q · filed 2015-08-05 | $2.18M 10-Q · filed 2015-08-05 | $2.00M derived: sum of 3 quarters · filed 2015-08-05 | $3.50M derived: sum of 4 quarters · filed 2015-11-02 | |||
| 2015-03-31 | $4.16M 10-Q · filed 2015-05-05 | $3.98M derived: sum of 2 quarters · filed 2015-05-05 | $5.48M derived: sum of 3 quarters · filed 2015-11-02 | $6.27M derived: sum of 4 quarters · filed 2015-11-02 | |||
| 2014-12-31 | -$175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $1.32M derived: sum of 2 quarters · filed 2015-11-02 | $2.11M derived: sum of 3 quarters · filed 2015-11-02 | $2.93M 10-K · filed 2015-03-02 | |||
| 2014-09-30 | $1.49M 10-Q · filed 2015-11-02 | -$1.49M 10-Q · filed 2014-10-28 | $2.28M derived: sum of 2 quarters · filed 2015-11-02 | $3.11M 10-Q · filed 2015-11-02 | -$3.10M 10-Q · filed 2014-10-28 | $12.86M derived: sum of 4 quarters · filed 2015-11-02 | |
| 2014-06-30 | $790.00K 10-Q · filed 2015-08-05 | -$791.00K 10-Q · filed 2014-07-31 | $1.61M 10-Q · filed 2015-08-05 | -$1.61M 10-Q · filed 2014-07-31 | $11.37M derived: sum of 3 quarters · filed 2015-08-05 | $6.07M derived: sum of 4 quarters · filed 2015-08-05 | |
| 2014-03-31 | $821.00K 10-Q · filed 2015-05-05 | -$821.00K 10-Q · filed 2014-05-02 | $10.58M derived: sum of 2 quarters · filed 2015-05-05 | $5.28M derived: sum of 3 quarters · filed 2015-05-05 | $4.48M derived: sum of 4 quarters · filed 2015-05-05 | ||
| 2013-12-31 | $9.76M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $4.46M derived: sum of 2 quarters · filed 2015-03-02 | $3.65M derived: sum of 3 quarters · filed 2015-03-02 | $3.54M 10-K · filed 2015-03-02 | |||
| 2013-09-30 | -$5.30M 10-Q · filed 2014-10-28 | -$6.10M derived: sum of 2 quarters · filed 2014-10-28 | -$6.22M 10-Q · filed 2014-10-28 | ||||
| 2013-06-30 | -$805.00K 10-Q · filed 2014-07-31 | -$925.00K 10-Q · filed 2014-07-31 | |||||
| 2013-03-31 | -$120.00K 10-Q · filed 2014-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |